Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
National framework to strengthen UK advanced therapy clinical trials
Hidden mechanism in DNA damage
Base to Base biotech podcast 56: GRIN genes and relapsing MS
Positive first-in-human data for IVF-related embryo implantation failure treatment
New company plans to replace daily injections with implant
UCB adds epilepsy drug through Neurona Therapeutics acquisition
Mechanism ‘opens new era’ for targeted cancer therapy
myTomorrows and Rare Disease Research partner to improve access to rare disease clinical trials
Resolve Therapeutics and Institut Pasteur collaborate to identify cell-free RNA triggers in autoimmunity